CureusCardiology

The Cureus Journal of Medical Science
Open Access, Peer-reviewed
Cardiology & Cardiac/Vascular Surgery Specialties
Main Account: @CureusInc

[CureusCardiology @CureusCardiac]

This case raises important questions about long-term cardiovascular monitoring in patients receiving JAK inhibitors. Has recent safety data changed your prescribing practices for JAK inhibitors?

Read more: https://t.co/Ga0E3J6Msn

#Cureus #Rheumatology #Cardiology #MedEd

[CureusCardiology @CureusCardiac]

This review reminds clinicians that ambient scribe notes are interpretations, not recordings. Every AI-generated note still requires human judgment. Would you trust AI to document your patient encounters?

Read more: https://t.co/ehtRWDDhK3

#Cureus #ArtificialIntelligence #MedEd

[CureusCardiology @CureusCardiac]

Not all hypertension is created equal. This study found elevated aldosterone-renin ratios in 26% of hypertensive patients. A potentially treatable endocrine cause may be hiding behind hypertension.

Read more: https://t.co/3R5zYdzllx

#Cureus #Hypertension #Endocrinology #MedEd

[CureusCardiology @CureusCardiac]

This review suggests early combination therapy may improve long-term outcomes in type 2 diabetes. Timing may be the most important treatment decisions we make. Has the evidence changed your approach?

Read more: https://t.co/1J5YfGq1nF

@nirajlodha2001

#Cureus #Diabetes #MedEd

[CureusCardiology @CureusCardiac]

Synthetic semaglutide is raising new questions about: quality, regulation & clinical comparability. In biologic-style therapies, how a drug is made may matter as much as the molecule itself.

Read more: https://t.co/qqTDRK9dSh

#Cureus #Semaglutide #GLP1 #MedEd

[CureusCardiology @CureusCardiac]

Advanced cardiovascular disease presents unique challenges: uncertain prognosis, fluctuating decline, complex device decisions. Cardiology may need a more active role in end-of-life policy and communication.

Read more: https://t.co/aCT8N1FA7Y

#Cureus #Cardiology #HeartFailure

[CureusCardiology @CureusCardiac]

In this neurology case, an AI copilot closely matched clinical care for CAA + MCI. AI may improve access to knowledge, but medicine still requires judgment. Would you use AI support during patient care?

Read more: https://t.co/yuCt4qhTer

#Cureus #AI #Neurology #MedEd

[CureusCardiology @CureusCardiac]

@LTipitaka88 Thank you for highlighting this important connection between scientific evidence and policy.

[CureusCardiology @CureusCardiac]

Dr. Shahbaz Salehi shares why he chose Cureus-strong editorial support, an easy publishing platform, and open access visibility for clinically relevant research. Contribute your story: https://t.co/aSjzmTuu4g

#WhyIChoseCureus #Cureus #OpenAccess #CardiacSurgery #MedEd

[CureusCardiology @CureusCardiac]

@LTipitaka88 @hthgovgh @LuccaHealthMSC Thank you for sharing this perspective and resource.

[CureusCardiology @CureusCardiac]

Many patients had normal EF but abnormal LV strain, strongly linked to obesity and hypertension. LVGLS may detect heart failure before symptoms begin.

Read more here: https://t.co/VGA89Kk41u

@hthgovgh, @LuccaHealthMSC
#Cureus #Cardiology #HeartFailure #Echocardiography #MedEd

[CureusCardiology @CureusCardiac]

This congenital defect usually presents in infancy. In this case, favorable drainage anatomy delayed diagnosis until adulthood. Have you ever diagnosed CHD unexpectedly in an adult?

@dr_bhendevishal

Read more: https://t.co/poWRXofQu2

#Cureus #Cardiology #MedEd

[CureusCardiology @CureusCardiac]

Imaging revealed: abnormal aortic wall, central hypoechoic lesion & unusual vessel-like structure. Which modality would you rely on next; CT, TEE, or something else?

Read more: https://t.co/YnFgMcFlAD

#Cureus #Cardiology #TEE #MedEd

[CureusCardiology @CureusCardiac]

The HEARTLAND Protocol provides a step-by-step framework for delivering HF care in rural, low-resource settings. From admission → long-term management. What’s missing more, new drugs or better systems?

Read more: https://t.co/a5g65rAe6p

#Cureus #HeartFailure #MedEd

[CureusCardiology @CureusCardiac]

This 11-year case suggests: Dynamic CMB clustering → ICH, Rapid lobar CMB rise → seizures, Plateau → stabilization. Are we underusing longitudinal MRI patterns in small vessel disease?

Read more: https://t.co/Tp4UzEKnCR

#Cureus #Neurology #Stroke #Epilepsy #Neurology #MedEd

[CureusCardiology @CureusCardiac]

When vomiting isn’t “just a side effect”

Severe vomiting → oesophageal perforation.

Takeaway: Not all “GI side effects” are minor.

💬 Should GLP-1 prescribing come with stricter escalation safeguards?
Yes / No

Read more: https://t.co/osCaAbisdB

#cureus #Obesity #MedEd

[CureusCardiology @CureusCardiac]

This case showed early PVC improvement with EAT, followed by delayed cognitive recovery. Does this change how you think about autonomic dysfunction in Long COVID?

Read more: https://t.co/58D95ysybP

#Cureus #COVID #AutonomicDysfunction #Cardiology #MedEd

[CureusCardiology @CureusCardiac]

Are SGLT2 inhibitors lipid-neutral or lipid-friendly? 👀

This review leans toward neutral → mildly favorable.

💬 Agree or disagree. What’s your experience?

Read more: https://t.co/oSsexMYFtS

#cureus #DiabetesCare #CardioMetabolic #MedEd

[CureusCardiology @CureusCardiac]

Cardiac rehab improves outcomes in LVAD patients, but inspiratory muscle training is rarely addressed, despite major diaphragm adaptations. Do current rehab programs go far enough?

Read more: https://t.co/rNrczYBTi4

#Cureus #HeartFailure #Pulmonology #CriticalCare #MedEd

[CureusCardiology @CureusCardiac]

Short-term survival same. Long-term risk higher. Is COVID changing Takotsubo outcomes in ways we’re underestimating?

Read more: https://t.co/Vw8qaNTiKK

@Dr_D_Meyah
#Cureus #Cardiology #COVID19 #Takotsubo #MedEd

[CureusCardiology @CureusCardiac]

Cureus Japan is live.

A localized gateway to open-access, PubMed-indexed medical research—supporting global visibility and collaboration.

https://t.co/5sNZtMauc7

#cureus #OpenAccess #CureusJapan #GlobalHealth #Research